Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|March 23, 2000
The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layersJ K Tunggal, T Melo, J R Ballinger, et al.
The American Journal of the Medical Sciences|July 1, 1989
Metastatic carcinoma of unknown primary: complete response to second-line treatment with plicamycinH Hescock, M Parker, T Y Wang, et al.
Annals of Nuclear Medicine|February 1, 1993
Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humansH Toyama, M Ichise, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Simplified quantification and reproducibility studies of dopamine D2-receptor binding with iodine-123-IBF SPECT in healthy subjectsM Ichise, J R Ballinger, D Vines, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoproteinJ R Ballinger, K M Sheldon, I Boxen, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1984
The natural history of behavioural symptoms among severely and profoundly mentally retarded patientsA H Reid, B R Ballinger, B B Heather, et al.
Nuclear Medicine Communications|June 10, 2017
A 99mTc-labelled scFv antibody fragment that binds to prostate-specific membrane antigenSaima Nawaz, Gregory E D Mullen, Philip J Blower, et al.
Psychological Medicine|August 1, 1980
The possible relationship of herpes simplex virus infection to cause of retardation in severe mental handicapA H Reid, K W Martin, B R Ballinger, et al.
Clinical Nuclear Medicine|June 1, 1990
Cerebral perfusion imaging with technetium-99m HMPAO following cerebral trauma. Initial experienceR H Reid, K Y Gulenchyn, J R Ballinger, et al.
British Journal of Urology|February 1, 1995
A novel anti-seminoma monoclonal antibody (M2A) labelled with technetium-99m: potential application for radioimmunoscintigraphyA Marks, J R Ballinger, R M Reilly, et al.
Pageof 18